Biogen (BIIB) Retained Earnings (2009 - 2026)

Biogen (BIIB) has reported Retained Earnings for 18 consecutive years, with -$140.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Retained Earnings fell 100.72% year-over-year to -$140.2 million; the TTM figure through Mar 2026 stood at -$140.2 million (down 100.72% YoY), while the FY2025 annual figure was $20.6 billion, up 6.71% from the prior year.
• Retained Earnings came in at -$140.2 million for Q1 2026 at Biogen, down from $20.6 billion in the prior quarter.
• The five-year high for Retained Earnings was $20.6 billion in Q4 2025, with the low at -$214.8 million in Q3 2025.
• Average Retained Earnings over 5 years is $6.7 billion, with a median of -$140.2 million recorded in 2026.
• The largest YoY upside for Retained Earnings was 13891.16% in 2025 against a maximum downside of 101.13% in 2025.
• Year by year, Retained Earnings stood at -$164.9 million in 2022, then surged by 10789.87% to $17.6 billion in 2023, then gained by 9.26% to $19.3 billion in 2024, then advanced by 6.71% to $20.6 billion in 2025, then plunged by 100.68% to -$140.2 million in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered -$140.2 million, $20.6 billion, and -$214.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.